Matthew Taylor
Stock Analyst at Jefferies
(2.62)
# 2,062
Out of 5,242 analysts
185
Total ratings
59.29%
Success rate
9.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $110 → $100 | $56.67 | +76.46% | 2 | Apr 22, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $220 → $190 | $146.95 | +29.30% | 5 | Feb 10, 2026 | |
| PEN Penumbra | Downgrades: Hold | $335 → $374 | $327.38 | +14.24% | 2 | Jan 16, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $64.26 | +63.40% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $156.59 | +126.71% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $82.97 | +18.11% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $14.88 | +27.69% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $88.38 | +64.06% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.02 | +6.99% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $78.15 | -2.75% | 17 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $107 → $121 | $178.79 | -32.32% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.98 | +251.76% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $15.04 | +199.20% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $5.71 | +75.13% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $15.39 | +244.38% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $10.13 | +136.92% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $321.49 | +7.31% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $85.38 | +52.26% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $14.82 | +34.95% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $37.01 | +129.67% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $84.03 | -10.75% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $209.86 | +16.74% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $18.77 | +230.31% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $135.18 | +55.35% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $8.24 | +45.63% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $71.44 | +74.97% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $449.03 | -53.23% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $73.71 | +30.24% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $4.39 | +59.45% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $11.81 | +35.48% | 2 | Jul 19, 2017 |
Boston Scientific
Apr 22, 2026
Maintains: Buy
Price Target: $110 → $100
Current: $56.67
Upside: +76.46%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Buy
Price Target: $220 → $190
Current: $146.95
Upside: +29.30%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $335 → $374
Current: $327.38
Upside: +14.24%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $64.26
Upside: +63.40%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $156.59
Upside: +126.71%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $82.97
Upside: +18.11%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $14.88
Upside: +27.69%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $88.38
Upside: +64.06%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.02
Upside: +6.99%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $78.15
Upside: -2.75%
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $178.79
Upside: -32.32%
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $3.98
Upside: +251.76%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $15.04
Upside: +199.20%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $5.71
Upside: +75.13%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $15.39
Upside: +244.38%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $10.13
Upside: +136.92%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $321.49
Upside: +7.31%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $85.38
Upside: +52.26%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $14.82
Upside: +34.95%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $37.01
Upside: +129.67%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $84.03
Upside: -10.75%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $209.86
Upside: +16.74%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $18.77
Upside: +230.31%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $135.18
Upside: +55.35%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $8.24
Upside: +45.63%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $71.44
Upside: +74.97%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $449.03
Upside: -53.23%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $73.71
Upside: +30.24%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $4.39
Upside: +59.45%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $11.81
Upside: +35.48%